May 28th 2025 Article Tasked with the delivery of two ultra-sensitive gene therapies to Japan – treatments targeting vision loss that required continuous -80°C temperature control and dry ice replenishment…
In this exclusive PC Podcast interview, Alice Valder Curran, partner at Hogan Lovells, explores: How recent executive orders—both under the Biden and Trump administrations—have reshaped the drug pricing landscape, and…
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption…
Image Credit: Adobe Stock Images/PostModernStudio.com Key Takeaways Full interchangeability approved: The FDA has granted full interchangeability to Hadlima for all Humira formulations, allowing pharmacist substitution without prescriber consultation (per state…
In a video interview with Pharma Commerce, Scott Tillman, Logility’s senior vice president of innovation, addresses the gap between high interest in generative AI (GenAI) and its relatively low adoption…
Image Credit: Adobe Stock Images/Feodora.com Main Takeaways The merger of Mercalis and PharmaCord, backed by Permira and Odyssey Investment Partners, forms Valeris—a platform aimed at streamlining how life sciences companies…
The pharmaceutical industry stands at the threshold of a long-overdue transformation in how serialization is approached, implemented, and managed. For more than a decade, serialization has largely been driven by…
Temperature-Sensitive Tech: Cold Chain's Continuous Development
PC: You recently delivered a keynote presentation surrounding “How to Integrate E2E and Deliver ‘Miracles of Science’ to your Patients.” Could you provide a brief synopsis of what your session…
Key Takeaways Personalized medicine demands precision logistics, with strict temperature control, real-time tracking, and regulatory compliance essential to ensure safe and timely delivery of patient-specific therapies. Gaps in last-mile delivery…
HPV Vaccine: Balancing Benefits, Risks, and Public Perception Despite ongoing lawsuits and public concerns about serious adverse events, current evidence supports the safety and effectiveness of the human papillomavirus vaccine…
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in…
Image Credit: Adobe Stock Images/PeterHansen.com Key Takeaways Noom is now offering its own compounded version of semaglutide—an active ingredient in Wegovy and Ozempic—through its telehealth marketplace. The FDA has ended…
PC: How would you define successful E2E, and what specific processes are necessary in order to achieve this? Beadle: The first thing I’d highlight—and I mentioned this in the keynote—is…
Bridging Innovation and Trust with Artificial Intelligence In a recent interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, discussed how AI is transforming clinical trials by…
Credit: Production Perig | stock.adobe.com Key Takeaways Embrace Real-Time Data for Proactive Supply Chain Management. Advanced manufacturing and real-time analytics help pharmaceutical companies predict and prevent drug shortages. Just like…
The Role of AI in Solving Clinical Trial Diversity and Access Challenges In an interview with Applied Clinical Trials, Michel van Harten, MD, CEO of myTomorrows, explained how AI can…
PC: How do you see the potential impact of HHS’s proposed policy change on patient advocacy efforts, particularly for rare and serious diseases? Leuchter: If I step back and think…
Main Takeaways 503B outsourcing facilities must comply with various FDA regulations, including current good manufacturing practices (cGMP), registration, labeling, and adverse-event reporting requirements, which distinguish them from 503A pharmacies and…
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in…
Image Credit: © JHVEPhoto – stock.adobe.com Key takeaways Placebo-controlled trials now required for low-risk groups: FDA will require placebo-controlled trials for COVID-19 vaccines in low-risk populations before granting full approval—adding…
Less is More in Clinical Data: The Road to Simpler and Better Trials In an article for Applied Clinical Trials, Drew Garty, chief technology officer, Veeva, emphasizes that simplifying clinical…
Image Credit: Adobe Stock Images/Weerasak.com The Low-Income Subsidy, or “Extra Help,” significantly reduces prescription drug costs for 14 million Medicare beneficiaries with limited income and resources. The Inflation Reduction Act…
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in…
Image Credit: Adobe Stock Images/GorodenKoff.com Invensify and GO2 Delivery’s partnership significantly reduces cold chain packaging costs—by up to 50%—while ensuring regulatory compliance for temperature-sensitive medications. The collaboration promotes sustainable healthcare…
Navigating the Payer-Health System Nexus: A Strategic Imperative for Biopharma Commercial Success Biopharma companies must adopt integrated strategies that engage both payers and health systems—each now powerful, parallel decision-makers—to overcome…
Image Credit: Adobe Stock Images/LucianoLuppa.com 1. Leadership shakeup amid crises: UnitedHealth Group CEO Andrew Witty has abruptly stepped down, citing personal reasons. His departure follows a year of major turmoil…
Image Credit: Adobe Stock Images/Suriyo.com 1. Five-step repurposing process: The study outlined a five-stage process: enabling, identifying, validating, testing, and implementing repurposed drugs. 2. RDNPs drive success: Nonprofit involvement, especially…
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in…
Pharmaceutical Commerce: What specific pricing practice by pharmacy benefit managers (PBMs) does the Protecting Pharmacies in Medicaid Act aim to address? Anne Cassity: The Protecting Pharmacies in Medicaid Act really…
A Closer Look at NIH Grant Terminations In an interview with Applied Clinical Trials, Harvard Medical School researcher Michael Liu discussed a recent study analyzing NIH grant terminations, revealing that…
PC: As the head of global supply chain, what does your day-to-day workflow typically consist of? Beadle: Our primary responsibility is getting products to patients—that’s at the heart of what…
Five questions on Trump’s plan to lower US drug prices President Trump’s new plan to lower US drug prices by tying them to the lowest prices paid in other countries…
In a video interview with Pharma Commerce, Kevin Dondarski, Deloitte’s life sciences R&D strategy leader, describes how his company’s 15th annual Deloitte report on the return on investment (ROI) in…
Bluebird bio warns of potential bankruptcy as buyout faces another delay Bluebird bio has warned of possible bankruptcy after buyers Carlyle and SK Capital extended their acquisition deadline yet again…
Image Credit: Adobe Stock Images/MAlfanSetyawan.com It’s no secret that for years, critics have commented about the prices for medication in the UnitedStates being exorbitantly high. In response to this issue,…
White House Unveils Pharma Most-Favored-Nation Executive Order Pharmaceutical Executive reported that President Trump issued an executive order titled Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, aiming to lower US…
Rendering of the new Lexington sterile fill-finish facility. Image Credit: Piramal Pharma Ltd. Piramal Pharma Limited, a global pharmaceuticals and wellness company, will be investing $90 million toward growing two…
FDA chief Martin Makary sets June deadline for genAI rollout FDA Commissioner Martin Makary has set a June 30, 2025 deadline for full agency-wide rollout of generative AI to streamline…
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of…
Teva plots thousands of job cuts as restructuring drive enters ‘acceleration’ phase Teva is set to cut around 2,400 jobs, about 8% of its workforce, as part of its “Acceleration…
In this video, Josh Marsh, Vice President and General Manager of Cardinal Health Sonexus™ Access and Patient Support, discusses the balance between technology and human interaction to support patients and…
In a video interview with Pharma Commerce, Michael Rowe, Two Labs’ senior director of DSCSA/serialization compliance services, describes how the HDA Distribution Management Conference (DMC) covers a broad spectrum of…
The latest wave of artificial intelligence (AI), digital health, and direct-to-patient (DTP) models have the potential to drive significant innovation, transform patient experiences, and redefine business and operating models across…
J&J survey finds pace of oncology innovation is overwhelming physicians A recent J&J survey reveals that oncologists are overwhelmed by the rapid pace of oncology innovation, highlighting the need for…
The ETF-300. Image Credit: Antares Vision Group Antares Vision Group, a provider of track-and-trace systems for several fields including the life sciences, is growing its solutions portfolio to now include…
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted…
Image Credit: Adobe Stock Images/N0m3rcy.com SK pharmteco, a contract development and manufacturing organization (CDMO), has opened a new, 300,000 square-foot current good manufacturing practice (CGMP) plasmid suite at its plant…
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state…
At this year’s Asembia Summit, Pharmaceutical Commerce sat down with Blake Powers, CEO of Medigi, to discuss the company’s role in bridging innovation and patient access in the life sciences…
As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has become more critical than ever—particularly for individuals with chronic and…
In an interview with Pharmaceutical Commerce, Chip Parkinson, the new CEO of Gift Health, shared his perspective on stepping into the role and the evolving challenges and opportunities across the…
Being proactive with and responsive to your environmental monitoring (EM) data helps prevent problems with cleanroom contamination. Learn more about EM and cleanroom best practices and to see how ABM…
March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems that taxed their staff and too many manual processes that…
Image Credit: Nicholas Saraceno The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on “Navigating the IRA: What Have We Learned?…
April 30, 2025 Amy Niles, chief mission officer, PAN Foundation, discusses the latest changes to the Medicare program that have the potential to improve patient access to care, along with…
Image Credit: Nicholas Saraceno The final day of education at Asembia’s AXS25 Summit kicked off with a multitude of early morning sessions, including one focused on “Beyond Limits: Rethinking Drug…
Multimorbidity and associated polypharmacy, including use of potentially inappropriate medication (PIM), are an increasing challenge for European health systems. A lack of cross-national studies using standardized methodology and comparable study…
Image Credit: Nicholas Saraceno The afternoon sessions here on day 3 of Asembia continued its impressive slate, with its various business seminars as proof. One of which was centered around…
The second day of Asembia’s AXS25 Summit featured a session that addressed a distinct set of challenges facing the pharmaceutical industry. Titled “Beyond the Headlines: What Pharma Leaders Must Know…
In an interview with Pharmaceutical Commerce, Will Pih, co-founder, Two Labs, shared insights from his recent panel discussion on “Economics and Specialty Pharmacy for Rare Diseases: Challenges and Opportunities.” The…
In an interview with Pharmaceutical Commerce, Fran Gregory, VP, emerging therapies, Cardinal Health, shared key insights into the evolving landscape of cell and gene therapies. Speaking about the current state…
In an interview with Pharmaceutical Commerce, a session leader from “U.S. Pharmaceutical Transitions: What’s Next?” shared key insights on the current and future state of the market. The conversation highlighted…
Image Credit: Nicholas Saraceno Here at Asembia’s AXS25 Summit in Las Vegas, attendees were treated to behind-the-scenes insight regarding “Commercialization Considerations for Orphan/Rare, Cell & Gene, and Precision Medicine.” Led…
As the healthcare industry sharpens its focus on patient-centered care, addressing social determinants of health, health equity, and literacy has become more critical than ever—particularly for individuals with chronic and…
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing…
Regeneron, Roche Launch Major US Expansion Plans to Meet Growing Demand for Biologics and Innovation Regeneron and Roche are investing a combined $53 billion over the next decade to expand…
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing…
Understanding the True Meaning of Risk in Clinical Trial Operations In a recent interview with Applied Clinical Trials, Rob Jones of Pharmalex emphasized the need for TMF leaders to adopt…
Roche in ‘Very, Very Good Position’ To Weather Trump Tariffs but M&A May Suffer Roche expects to weather the financial impact of Trump-era tariffs due to its strategic US manufacturing…
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing…
Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.
In a video interview with Pharma Commerce, Paul Levesque, CEO of Theratechnologies, explains how Theratechnologies’ operations have been impacted by recent US tariffs on Canadian goods, especially concerning the manufacturing…
Image Credit: Business Wire PCI Pharma Services, a contract development and manufacturing organization (CDMO), will be purchasing a full stake in Ajinomoto Althea, Inc., a sterile fill-finish CDMO and subsidiary…
Image Credit: Adobe Stock Images/OMS.com The International Air Transport Association (IATA) is celebrating 10 years of its Center of Excellence for Independent Validators (CEIV) program, which evaluates a company’s the…
PC: How can stakeholders ensure that sustainability takes precedence, even over other important business drivers? Ganguly: There are three key takeaways from the panel—and from observing how the sustainability movement…
Image Credit: Adobe Stock Images/Kotchakorn.com Among the older population, polypharmacy—the use of five or more medications—has skyrocketed. The issue lies in the fact that some meds lack any sort of…
PC: You just wrapped up a panel discussion on “Uniting on Sustainability: How can we drive collaboration and ground-breaking initiatives to ensure ESG is a top business priority?” With sustainability…
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization…
Image Credit: Thermo Fisher Scientific Thermo Fisher Scientific has officially opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, CA.1 The plant is intended to speed up both the development…
In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key sessions: “Establishing and Transitioning to a Foundation” and “Empowering Patients…
Pharma companies expected to absorb any tariff hit in short term While US tariffs on pharmaceuticals may eventually raise drug prices, especially for generics, experts say brand-name costs will likely…
Image Credit: Adobe Stock Images/Monchisa The FDA has granted interchangeability designation to Celltrion’s Yuflyma (adalimumab-aaty), a high-concentration (100 mg/mL), citrate-free biosimilar of Humira (adalimumab), across multiple inflammatory indications. The designation…
Bringing Biotech Innovation Across Borders A feature published by Pharmaceutical Executive authored by Ed Ahn, CEO of MEDIPOST, Inc, outlines four tips for midsized companies when entering new global markets.…
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization…
For a child with autism spectrum disorder (ASD), effective care coordination across the required medical, physical rehabilitation, counseling, occupational, and speech providers is challenging, especially when the aim is to…
In a video interview with Pharma Commerce, Jody Hatcher, CEO of Morris & Dickson and chair of HDA’s board of directors, outlines his vision for the future of the organization…
PC: How do you manage to keep the program itinerary organized year after year? Robinson: While we have a broader global LogiPharma portfolio, my team now focuses solely on this…
Image Credit: Adobe Stock Images/Metamorworks.com There is a new contract development and manufacturing organization (CDMO) in the marketplace. With the ultimate goal of boosting patient health through its manufacturing services,…
PC: When comparing this year to previous years, how would you say the main discussion points of LogiPharma have evolved? Robinson: I’m sure I’m not the only one saying this,…
Pharmaceutical Commerce: April 2025 Interactive Digital Edition The Cold Chain’s Evolution Tariffs Galore: Where Do We Stand? Conference Connect: Progressing Patient Assistance The Hot Market for Cold Chain Services Reducing…
PC: What was the thought process behind moving LogiPharma to Vienna in 2026? Robinson: Robinson: First and foremost, it’s about the capabilities of the venue. Lyon has been wonderful and…
The pharmaceutical cold chain sector plays a crucial role in ensuring the safe and effective delivery of temperature-sensitive medications, including advanced therapy medicinal products (ATMPs). For the last decade, it’s…
Logistics play a very important role in the pharmaceutical industry, as the activities involved are highly sensitive to time and quality control. It involves delivering drugs to the right place,…
PC: What general advice do you have for other pharma supply chain stakeholders when it comes to delivering change that boosts growth, augments pipelines, and increases productivity? Lang: First of…
Long-Term Sustainability for Diverse Trial Initiatives LaShell Robinson, head of global feasibility and trial equity at Takeda, discusses how Takeda will ensure that diversity and inclusion remain a priority in…
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to…
PC: How can technology play a role in implementing these changes, and what challenges can it help overcome? Lang: Technology has fundamentally changed our lives outside of work—and it has…
One of the objections I sometimes hear when discussing counterfeiting and diversion challenges with pharmaceutical manufacturers, particularly smaller ones, is that they just don’t know enough about the problem. They…
Let’s start with an alarming pair of statistics. First, 40% of specialty product prescriptions actually get filled, and second, when a patient’s copay or out-of-pocket cost exceeds $250, the abandonment…
Welcome to the third installment of my “Popping the Gross-to-Net Bubble” series. In my previous column, I explored actionable steps pharmaceutical manufacturers can take to address gross-to-net (GTN) challenges for…
Healthcare costs, insurance barriers, and medical debt are preventing patients with chronic illnesses in the US from accessing essential treatments and medications. That’s according to the PAN Foundation’s Center for…
Image Credit: Nicholas Saraceno LogiPharma Europe continued its star-studded lineup featuring Big Pharma, with a morning keynote case study on “Rethinking Your C> Value Chain: How to Ensure Readiness for…
When I was penning my latest column for Pharma Commerce, I felt that various recent developments were worth noting, considering the impact they could have on the US prescription drug…
The COVID-19 pandemic highlighted our supply chains’ weaknesses like never before. A sudden surge in demand and limited production capabilities led to critical shortages of medical supplies, pharmaceuticals, and even…
Developing effective lifesaving drugs requires significant research and development (R&D) investments. New medications cost an average of $2.3 billion to develop,1 largely funded by existing drug sales. At the same…
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to…
Image Credit: Adobe Stock Images/MichaelVi Boehringer Ingelheim announced the official opening of a new antibody-drug conjugate (ADC) research and development facility in Basel, Switzerland, through its wholly owned subsidiary, NBE…
Balancing Cost-Efficiency with the Need for Domestic Manufacturing Marcel Botha, CEO of 10XBeta, discusses finding a balance between the need for cost-efficiency and the need to build domestic manufacturing capacity…
Analyzing the Theranos Appeals Matthew Yelovich, partner at Cleary Gottlieb, discusses the appeals of Elizabeth Holmes and Ramesh “Sunny” Balwani and the Ninth Circuit’s recent affirmation of their convictions. Current…
In a video interview with Pharma Commerce, Rachel Thorpe, executive director at the Otsuka Patient Assistance Foundation, discusses two key sessions: “Establishing and Transitioning to a Foundation” and “Empowering Patients…
Google Gemini, AI Commercialization in Pharma and More Google recently released an updated version of its AI LLM. Gemini 2.5 Pro boasts a variety of new features that could help…
In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant challenges in accessing GLP-1 drugs due to their high cost.…
Image Credit: Adobe Stock Images/Tun.com Siemens AG, a technology conglomerate, has acquired Dotmatics, an R&D scientific software company, from private equity firm Insight Partners for $5.1 billion.1 “By acquiring Dotmatics,…
In a video interview with Pharma Commerce, Colin Banas, MD, DrFirst’s chief medical officer, describes have many Americans face significant challenges in accessing GLP-1 drugs due to their high cost.…
Image Credit: Adobe Stock Images/Bashirlrshad.com Yesterday afternoon, as reported by AP,1 US President Donald Trump announced that he will be enacting reciprocal tariffs on countries that are running trade surpluses…
In a video interview with Pharma Commerce, Kimberly Westrich, MD, chief strategy offer at the National Pharmaceutical Council, describes how in response to rising healthcare costs, employers have turned to…
Image Credit: Adobe Stock Images/Douglas.com A Reuters report1 noted that Hims & Hers began selling various Eli Lilly drugs on their platform—both branded forms of tirzepatide—including Zepbound, a glucagon-like peptide-1…
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Colin Banas, MD, DrFirst’s chief medical officer, discusses the challenges that many Americans face regarding the…
Oscar de Bok, CEO of DHL Supply Chain, and Jerrell Shelton, CEO of Cryoport. Image Credit: DHL Supply Chain DHL has purchased CRYOPDP, Cryoport’s specialty courier powered by clinical trials,…
PC: What are some of the biggest challenges in ensuring continued medication adherence for specialty patients? Butler: While technology and high-touch support are important, personalization is equally critical. Emotions fluctuate…
Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.
PC: How is the role of patient engagement evolving in specialty pharmacy? Butler: It’s becoming increasingly critical to evolve patient support in specialty pharmacy, as patients now expect more personalized…
Image Credit: Singota Solutions Following the launch of last year’s site in Rovello Porro, Italy,1 Singota Solutions, a contract development and manufacturing organization (CDMO), has opened a new 100,000 square-foot…
PC: What are some common barriers patients face when starting specialty medications, and how can peer-to-patient outreach help? Butler: Our program is a peer-to-patient platform, which I believe is critical.…
Image Credit: Adobe Stock Images/Orawan.com Eli Lilly and Company is growing its LillyDirect digital healthcare platform to offer independent in-person and telehealth support for people in the United States that…
PC: How does Pleio’s GoodStart program assist specialty pharmacies in improving patient engagement and adherence? Butler: Onboarding onto specialty medications is a complex and often overwhelming process for patients. That’s…
Image Credit: Adobe Stock Images/Pier.com Combined with research and manufacturing agreements, AstraZeneca is investing $2.5 billion into its sixth global strategic research & development (R&D) center in Beijing.1 The five-year…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry.…
Image Credit: Adobe Stock Images/Gaming.com Although the United States spends an exorbitant amount on healthcare, amounts across the individual states vary. In fact, studies have so that there are some…
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including…
Image Credit: Nicholas Saraceno The final day of Informa’s Access USA conference arrived quickly, and I decided to attend a session along the Hubs East track focused on “The Changing…
Image Credit: Nicholas Saraceno Informa’s Access USA conference from Philadelphia continued with its first panel discussion of the conference. Amy Niles, chief mission officer of the PAN Foundation—a national charitable…
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including…
New Ways of Targeting Cancer Company executives provide updates on cancer treatment pelareorep and other elements of the company’s pipeline. How Employers Can Support Employee Well-Being and Mental Health Trust…
The 2025 Medication Access Report: Biggest Bottlenecks for Patients Kimberley Chiang, vice president of biopharma commercial solutions at CoverMyMeds, highlights gaps in data sharing and cross-functional collaboration as major bottlenecks…
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including…
Image Credit: Nicholas Saraeno Day 2 of Informa’s Access USA track-based coverage carried on, with an afternoon session on the PAP track being run by Rachel Thorpe, executive director at…
Image Credit: Nicholas Saraceno Day 2 of Informa’s Access USA conference represented the start of its track-based sessions. In terms of the patient assistance & access program (PAP) focus of…
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including…
Image Credit: Nicholas Saraceno Informa’s Access USA conference leveraged its KOL base with a roundtable on “Unravelling the Complexities of Patient Access and Affordability.”1 Featuring Ian Ocilka, ConnectiveRx’s chief strategy…
Charitable donations have long been a vital lifeline for patients struggling to afford life-saving medications, particularly those with chronic and rare diseases. Over the past few decades, various assistance programs—including…
Image Credit: Nicholas Saraceno Day 1 of Informa’s Access USA Conference from Philadelphia—featuring Patient Assistance & Access Programs (PAP) and Hub and Specialty Models East—was kicked off by Tommy Bramley,…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry.…
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in…
It’s no secret that the pharmaceutical industry is facing a myriad of challenges and disruption, such as complex, costly, and lengthy new drug development; global regulatory hurdles; more start-ups entering…
March 14th 2025 Article Transitioning from manual temperature logs and reactive power outage management to a comprehensive cloud-based monitoring solution, Discount Drug Mart has revolutionized its approach to pharmacy operations…
November 21st 2024 Article The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven…
March 14th 2025 Article A regional hospital serving suburban Indianapolis, Hancock Regional Hospital faced a familiar challenge: disparate monitoring systems that taxed their staff and too many manual processes that…
Pre-Launch Prep for Emerging Biopharmas: Data First, Then the Rest Making early commercial data and analytics decisions for launch cen future-proof their data management. The Power of Three To Help…
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in…
Image Credit: Adobe Stock Images/WatermillStudio.com Cold Chain Technologies (CCT), a US-based provider of thermal packaging and digital monitoring solutions for the transportation of temperature-sensitive life sciences products, has acquired Global…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry.…
In a transaction officially set to close later this month, Syngene International Limited, a contract research, development, and manufacturing organization (CRDMO), acquired its first biologics site in the United States…
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in…
Image Credit: Adobe Stock Images/Mrzproducer.com PharmaCord LLC, a provider of patient services for the biopharmaceutical industry, and Mercalis, a life sciences commercialization partner, are merging to create a “total solutions…
Image Credit: Adobe Stock Images/Ketsara.com On Tuesday morning, as reported by AP,1 US President Trump announced that the original tax on steel and aluminum coming from Canada will double—increasing from…
In a video interview with Pharma Commerce, Jason C. Foster, CEO of Ori Biotech, describes how the current state of cell and gene therapies (CGTs) shows promising potential, particularly in…
In a video interview with Pharma Commerce, Brad Stewart, BDO’s national life sciences co-leader, describes the challenges that tariffs may pose to reshoring manufacturing services in the life sciences industry.…
The pharmaceutical manufacturing sector is experiencing a profound transformation driven by technological advancements, regulatory shifts, and market dynamics. Industry leaders are facing both unprecedented challenges and opportunities, making it essential…
Potential Tariff Impact on Availability & Accessibility of Medications for Telehealth Patients In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, discusses the impact of tariffs…
The Role Regulatory Agencies Should Play in the Battle Against Misinformation In this Pharmaceutical Executive video interview, Jen Butler, Chief Commercial Officer for Pleio, explores what kind of role regulatory…
Healthcare’s Visual Future: Shaping Trust Through Design The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their audiences. Direct Contracting:…
Image Credit: Adobe Stock Images/MariusFaust.com A couple days following a tax that had gone into effect on various goods coming in from Canada and Mexico, President Trump has decided to…
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming…
Image Credit: Adobe Stock Images/PinkEyes.com Astellas Pharma and YASKAWA Electric Corporation have signed a definitive agreement that officially commences a joint venture that revolves around the design of a cell…
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming…
Image Credit: Novo Nordisk Novo Nordisk, the manufacturer of Weggovy, is growing its offerings by creating NovoCare Pharmacy, a direct-to-patient (DTP) form of delivery that provides cash-paying patients with access…
PC: What are the legal implications of the latest tariffs—including the “reciprocal” variety—and what challenges do they present to the pharma supply chain? Lanton: Reciprocal tariffs could create significant disruptions…
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern…
It’s official—Trump’s tariffs on Canada and Mexico have now taken effect. In what the US president says is being tied to the threat posed by illegal aliens and drugs, including…
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern…
The landscape of healthcare provider (HCP) engagement has undergone a fundamental transformation. While traditional face-to-face interactions remain valuable, today’s HCPs interact across multiple channels throughout their day—from websites to social…
Delivering Personalized Experiences at Scale: A Fresh Look at Customer Centricity Customer centricity. An overused buzzword in the life sciences industry. Yet an important goal. In an era of eroding…
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern…
Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.
Image Credit: Adobe Stock Images/Natalia.com In early February, the news had originally broke that President Trump signed three executive orders that would enact tariffs on three key US trade partners:…
As the pharmaceutical landscape evolves, ensuring market access should remain a top priority for industry stakeholders. As we look ahead to a year of expected advancements, several key trends will…
Image Credit: Adobe Stock Images/StockMarketVisuals.com In an effort to increase its domestic medicine production across various therapeutic areas, Eli Lilly and Company will be constructing four new pharmaceutical manufacturing sites…
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern…
In a video interview with Pharma Commerce, Geoffrey Joyce, PhD, director of health policy at the Leonard D. Schaeffer Center for Health Policy & Economics at the University of Southern…
Image Credit: Adobe Stock Images/AvectStock.com President Trump recently signed an executive order providing greater healthcare price transparency for patients.1 The order, says the Trump Administration, is expected to help lower…
Image Credit: Adobe Stock Images/TadaImages.com Eli Lilly and Company is unveiling its new 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, which will be available for $499 per month…
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming…
Image Credit: Adobe Stock Images/Oporty786.com Selarsdi (ustekinumab-aekn) an injection for the treatment of psoriatic arthritis, plaque psoriasis, Crohn’s disease, ulcerative colitis, pediatric plaque psoriasis, and pediatric psoriatic arthritis that is…
In a video interview with Pharma Commerce, Tom Dorsett, CEO, RazorMetrics, describes how polypharmacy refers to the use of five or more medications by an individual, and it is becoming…
2025 Pipeline Report: The Edge of Greatness? The biopharmaceutical industry has long been at the forefront of innovation. From the rise of precision medicine, to artificial intelligence technologies accelerating drug…
Global Launch Strategies in the Current Political Climate James Foster, CEO and co-founder of Virax Biolabs, discusses how global launches are being impacted by changing geopolitical conditions. Pharmacists Help Patients…
Challenges in Developing T Cell Engagers Ian Chan, CEO of Abpro, discusses the advantages of their DiversImmune and MultiMab platforms for antibody discovery and engineering. Abpro’s platform can create novel…
James D. Chambers, PhD, MPharm, MSc James D. Chambers, PhD, MPharm, MSc, is a health economist by trade. After earning his MSc in Health Economics from the University of York…
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences…
Image Credit: Adobe Stock Images/FreshIdea.com The FDA has approved an expanded access program that will provide an alternative for Tice BCG—a Merck medication that treats various types of bladder cancer—to…
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences…
Image Credit: Adobe Stock Images/AndrzejTokarski.com After revealing a plan in which the United States would match the tax rates of what trading partners also charge on imports (as a way…
Navigating Distrust: Pharma in the Age of Social Media Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and…
Image Credit: Adobe Stock Images/Itsaree.com Many would agree that over the past five years or so, telehealth has skyrocketed in popularity, as another way to provide clinical healthcare, increasing access…
In a video interview with Pharma Commerce, Laura Johnson, senior director of sales, life sciences, Loftware, discusses how supply chain collaboration is becoming increasingly important, particularly in the life sciences…
The ChloraPrep Clear 1 mL Applicator. Image Credit: BD Becton, Dickinson and Company (BD), a medical technology (MedTech) company that produces and sells medical devices, laboratory equipment, and diagnostic products,…
In a video interview with Pharma Commerce, James Shehan, chair of the FDA Regulatory practice at Lowenstein Sandler, discusses the potential impact of upcoming tariffs on pharmaceutical supply chains, focusing…
Mike Hennessy Jr., President and CEO, MJH Life Sciences 2025 is upon us, officially marking a quarter of a century since Y2K and the midpoint of the decade. There is…